Approval of ANKTIVA was granted for BCG-unresponsive non-muscle-invasive bladder cancer (NMIBC) with carcinoma in situ, with ...
The collaborative clinical study will evaluate ADSTILADRIN® (nadofaragene firadenovec-vncg) in combination with the ...
Ferring Pharmaceuticals and Theralase® Technologies Inc. (TSXV:TLT) (OTCQB:TLTFF) are pleased to announce that they have ...
By default, metachronous bladder recurrences after UTUC surgery have been managed similarly to primary non-muscle invasive bladder cancer.
Stocktwits on MSN
IBRX stock finds retail cheer after company’s immunotherapy for bladder cancer gets Saudi FDA approval
ImmunityBio plans to establish a regional office in Saudi Arabia to support its expansion across the Middle East and North ...
InvestorsHub on MSN
Theralase and Ferring ink deal for new bladder cancer study
Theralase Technologies (USOTC:TLTFF) signed a clinical development agreement with Ferring Pharmaceuticals, a top name in ...
Urology, Ramaiah Institute of Nephro-Uro Sciences, Ramaiah Memorial Hospital, explains how robotic and minimally invasive ...
The Vancouver Sun on MSN
This made-in-B.C. preventive surgery lowers ovarian cancer risk
Opportunistic salpingectomy, or the removal of fallopian tubes in women already undergoing another abdominal or gynecological ...
I was living a normal 29-year-old life. I thought my symptoms were no big deal, until they started happening more ...
Even legends like Michael Westbrook are not safe from the wild world of social media. The Colorado icon became the center of ...
Jane Binney, from Whittington near Kirkby Lonsdale has completed four weeks of BCON radiotherapy at the Rosemere Cancer Centre.
Researchers also found that one in 14 day case surgery patients have new or worse chronic pain within three months of their ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback